Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer
Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
The Oncotype DX Breast Recurrence Score
®
assay is a clinically useful tool to determine the benefit of chemotherapy in the treatment of early-stage, hormone-receptor-positive breast cancer. Bilateral breast cancer (BBC) is found in ~ 5% of patients with breast cancer, and data regarding discordance of Oncotype DX results betwee...
Alternative Titles
Full title
Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2550264905
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2550264905
Other Identifiers
ISSN
1068-9265
E-ISSN
1534-4681
DOI
10.1245/s10434-021-10387-2
